BCAL Diagnostics Limited (ASX:BDX)
Australia
· Delayed Price · Currency is AUD 0.115
-0.005 (-4.17%)
Mar 9, 2026, 3:21 PM AEST
BCAL Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Operating Revenue | -0.09 | 0.02 | - | - | 0.72 | 0.28 | Upgrade
|
| Other Revenue | 2.63 | 2.63 | 3.05 | 2.79 | - | - | Upgrade
|
| Revenue | 2.54 | 2.65 | 3.05 | 2.79 | 0.72 | 0.28 | Upgrade
|
| Revenue Growth (YoY) | -1.26% | -13.01% | 9.18% | 288.29% | 161.09% | -37.74% | Upgrade
|
| Gross Profit | 2.54 | 2.65 | 3.05 | 2.79 | 0.72 | 0.28 | Upgrade
|
| Selling, General & Admin | 3.44 | 3.53 | 3.61 | 2.76 | 1.46 | 0.37 | Upgrade
|
| Research & Development | 4.85 | 4.46 | 4.36 | 4.47 | 1.91 | 0.66 | Upgrade
|
| Operating Expenses | 9.46 | 9.69 | 9.13 | 7.58 | 3.77 | 1.21 | Upgrade
|
| Operating Income | -6.92 | -7.04 | -6.08 | -4.79 | -3.05 | -0.93 | Upgrade
|
| Interest Expense | -0.15 | -0.09 | -0.1 | -0.02 | - | - | Upgrade
|
| Interest & Investment Income | 0.18 | 0.18 | 0.05 | 0.06 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.25 | -0.3 | -0.27 | -0.32 | -0.34 | -0.59 | Upgrade
|
| Pretax Income | -7.14 | -7.24 | -6.4 | -5.06 | -3.39 | -1.52 | Upgrade
|
| Net Income | -7.16 | -7.24 | -6.4 | -5.06 | -3.39 | -1.52 | Upgrade
|
| Net Income to Common | -7.16 | -7.24 | -6.4 | -5.06 | -3.39 | -1.52 | Upgrade
|
| Shares Outstanding (Basic) | 359 | 360 | 246 | 211 | 204 | 135 | Upgrade
|
| Shares Outstanding (Diluted) | 359 | 360 | 246 | 211 | 204 | 135 | Upgrade
|
| Shares Change (YoY) | 14.40% | 46.04% | 16.75% | 3.24% | 51.65% | 17.28% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 | -0.01 | Upgrade
|
| Free Cash Flow | -6.46 | -6.92 | -5.67 | -6.41 | -3.25 | -1.21 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -272.60% | -265.55% | -199.51% | -171.55% | -424.13% | -339.30% | Upgrade
|
| Profit Margin | -282.10% | -273.21% | -210.07% | -181.39% | -471.08% | -554.03% | Upgrade
|
| Free Cash Flow Margin | -254.48% | -261.23% | -186.23% | -229.72% | -451.54% | -439.70% | Upgrade
|
| EBITDA | -6.41 | -6.31 | -5.73 | -4.73 | -3.03 | -0.93 | Upgrade
|
| EBITDA Margin | -252.66% | -238.01% | -188.16% | -169.45% | - | - | Upgrade
|
| D&A For EBITDA | 0.51 | 0.73 | 0.35 | 0.06 | 0.02 | 0.01 | Upgrade
|
| EBIT | -6.92 | -7.04 | -6.08 | -4.79 | -3.05 | -0.93 | Upgrade
|
| EBIT Margin | -272.60% | -265.55% | -199.51% | -171.55% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.